Is it Possible to Estimate the Effect of Risedronat Treatment on Bone Mineral Density in Postmenapausal Osteoporosis by Biochemical Marker? - Original Investigation
In this study we aimed to evaluate and compare the effects of risedronate on bone mineral density (BMD) and biochemical markers in postmenopausal osteoporosis. One hundred three patients with postmenopausal osteoporosis were included in the study. The patients were divided into two groups as group 1...
Saved in:
Main Authors: | Ayhan Karadağ (Author), Kaan Uzunca (Author) |
---|---|
Format: | Book |
Published: |
Galenos Yayinevi,
2006-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correlation Between Digital X-Ray Radiogrammetry Findings and Bone Mineral Density in Postmenopausal Women
by: Kaan Uzunca, et al.
Published: (2005) -
The Effects of Risedronate Therapy Combined With Vitamin D and Calcium on Biochemical Markers of Bone Turnover and Bone Mineral Density in Postmenopausal Osteoporosis
by: Hüsniye Koç, et al.
Published: (2004) -
Assessment of Bone Mineral Density in Osteoporosis
by: Dilşad Sindel, et al.
Published: (2015) -
The Relationship Between the Results of Osteoporosis Risk Test and Bone Mineral Density - Original Investigation
by: Ferda Özdemir, et al.
Published: (2009) -
Comparison of the Effects of Strontium Ranelate and Raloxiphene on Bone Mineral Density in Postmenopausal Osteoporosis - Original Investigation
by: Figen Yılmaz, et al.
Published: (2009)